Table 1.
Final model | HR (95% CI) | P‐value |
---|---|---|
Classic | ||
Mitoses | 3.5 (1.4‐8.3) | 0.005* |
Extrascleral extension | 8 (2.5‐25.2) | <0.001* |
M3 | 3.1 (1.1‐9.1) | 0.04* |
Isochromosome 8q | 4.2 (1.7‐10.3) | 0.002* |
Clinical | ||
Stage | 2.5 (1.1‐5.8) | 0.03* |
Extrascleral extension | 3.2 (1.2‐8.3) | 0.02* |
Histology | ||
Epithelioid component | 2.1 (1.0‐4.1) | 0.04* |
Mitotic activity | 2.9 (1.3‐6.5) | 0.008* |
Necrosis | 2.1 (1.0‐4.6) | 0.06 |
CNA | ||
M3 | 11.0 (3.4‐35.7) | <0.001* |
8q+ | 3.9 (1.6‐9.2) | 0.002* |
LZTS1 deletion | 5.3 (2.2‐12.8) | <0.001* |
NBL1 deletion | 5.3 (2.2‐13.0) | <0.001* |
Immune‐CNA | ||
M3 | 9.2 (2.7‐31.1) | <0.001* |
8q+ | 3.6 (1.5‐8.7) | 0.005* |
LZTS1 deletion | 4.6 (1.8‐11.6) | 0.001* |
NBL1 deletion | 5.8 (2.3‐14.8) | <0.001* |
Immune infiltratea | 1.6 (0.7‐3.7) | 0.2 |
Immune forced into the model.
P ≤ 0.05 considered significant.